Abdominal and pelvic imaging: localization and pattern analysis
Abdominal and pelvic imaging reasoning begins with organ, compartment, clinical question and method. Review solid organs, bowel, vessels, urinary tract, pelvic structures and relevant extra-abdominal findings systematically. A lesion's enhancement can only be interpreted against the actual acquisition phases and comparison images. An attenuation value in one phase is not interchangeable with a true unenhanced value, and a timing label does not guarantee identical enhancement in every person.
Liver lesion patterns illustrate the need for context. Discontinuous peripheral nodular enhancement with progressive fill-in can favor a hemangioma. A lesion with hepatocellular function may behave differently on a hepatobiliary phase from one without that function. In a suitable high-risk population, arterial and later-phase characteristics contribute to named hepatocellular-carcinoma frameworks. Eligibility, morphology, size and framework version matter. Do not transfer a category rule automatically to a person outside the defined population or treat an arbitrary bright arterial lesion as proof of cancer.
Bowel assessment considers caliber, transition, configuration, wall, mesentery, enhancement and extraluminal findings. A closed loop with converging mesenteric structures is different from uncomplicated generalized distension. Pneumatosis and portal venous gas can be concerning, but their significance depends on associated findings and the clinical picture rather than an automatic claim of irreversible infarction in every case. Free gas, ischemic concern, a complicated collection or a rapidly deteriorating presentation may require urgent communication with the responsible team.
In the urinary tract, identify obstruction, calculi, collecting-system changes and parenchymal lesions using an appropriate protocol. A low-dose noncontrast stone examination is not the same protocol as a complete contrast-enhanced urographic assessment. Cystic renal-mass classifications require the specified morphology and acquisition conditions. Adrenal washout is a calculated feature, not a universal proof that a lesion is benign: some nonadenomas can overlap with commonly taught ranges. Interpret fat, attenuation, enhancement, clinical and hormonal context and appropriate further assessment together.
Pelvic imaging includes anatomical relationships as well as lesion signal. Endometriotic blood products, fibrous tissue, normal stromal structures and invasive disease can show different patterns, but no single sign replaces the full examination. Prostate, bladder, adnexal and rectal reporting frameworks address different questions and should not be mixed. Imaging can suggest depth, location or risk while pathology and the actual care pathway may still be required. Report the supported finding and relevant differential, not an invented treatment schedule or an assurance that one calculated threshold excludes every alternative.